Hulai Wei
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
Papers in
-
- Retinoids in leukemia and cellular processes 10
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- RNA Interference and Gene Delivery 3
- Metabolism, Diabetes, and Cancer 3
- Oncology 15
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Bei Xie (18 shared papers)Jing Chen (11 shared papers)Juan Yi (12 shared papers)Daqi Wang (1 shared paper)Weisheng Liu (1 shared paper)Xing Wang (1 shared paper)Xia Zhong (1 shared paper)Xing Zhong (1 shared paper)
- Journals
- Journal of Cancer (5 papers)Frontiers in Oncology (4 papers)Leukemia Research (2 papers)Oncology Reports (2 papers)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hulai Wei
50 papers receiving 765 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 138
- Oncology 225
- Physiology 27
- Molecular Biology 369
- Geriatrics and Gerontology 15
Countries citing papers authored by Hulai Wei
This map shows the geographic impact of Hulai Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hulai Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hulai Wei more than expected).
Fields of papers citing papers by Hulai Wei
This network shows the impact of papers produced by Hulai Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hulai Wei. The network helps show where Hulai Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Hulai Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 86 | |
| 2 | 2007 | 85 | |
| 3 | 2019 | 63 | |
| 4 | 2011 | 37 | |
| 5 | 2017 | 36 | |
| 6 | 2014 | 33 | |
| 7 | 2019 | 28 | |
| 8 | 2018 | 23 | |
| 9 | 2012 | 22 | |
| 10 | 2022 | 22 | |
| 11 | 2016 | 21 | |
| 12 | 2018 | 21 | |
| 13 | 2021 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2021 | 17 | |
| 16 | 2021 | 17 | |
| 17 | 2017 | 17 | |
| 18 | 2022 | 16 | |
| 19 | Arsenic trioxide inhibits p-glycoprotein expression in multidrug-resistant human leukemia cells that overexpress the MDR1 gene. | 2003 | 15 |
| 20 | 2018 | 15 |
About Hulai Wei
Hulai Wei is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Pharmacology, having authored 52 papers that have together received 776 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (11 papers), Retinoids in leukemia and cellular processes (10 papers), Drug Transport and Resistance Mechanisms (6 papers), RNA modifications and cancer (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA Interference and Gene Delivery (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (225 citations), Physiology (27 citations), Molecular Biology (369 citations) and Geriatrics and Gerontology (15 citations). Hulai Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bei Xie, Jing Chen, Juan Yi, Daqi Wang, Weisheng Liu, Xing Wang, Xia Zhong, Xing Zhong, Jing Sun and Zhuan Liu. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, Leukemia Research, Oncology Reports and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.